XtalPi Holdings Limited (2228)
2228 · Health Care ·
China
XtalPi Holdings Limited (2228) is a Chinese company in the Health Care sector. The stock has its largest weight in XCS6 (MSCI China), at 0.10%. Anyone who holds an ETF containing XtalPi Holdings Limited also has an indirect stake in the company.
Data and Charts: XtalPi Holdings Limited
Key Data for XtalPi Holdings Limited
Alysly Data Analysis: XtalPi Holdings Limited
What ETF Is XtalPi Holdings Limited In?
XtalPi Holdings Limited has average ETF coverage and is held by 10 of the 104 ETFs we track, which together follow 5 indices. That puts the stock in more ETFs than 63.9% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XCS6 / XCS7 | MSCI China | 0.10% | €0.99 |
| IS3N | MSCI EM IMI | 0.02% | €0.20 |
| SPYM | MSCI Emerging Markets | 0.02% | €0.19 |
| XMME / XEMD | MSCI Emerging Markets | 0.02% | €0.19 |
| SPYY | MSCI ACWI | < 0.01% | < €0.05 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
| IUSQ | MSCI ACWI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to XtalPi Holdings Limited, based on each fund's latest holdings list.
US-listed ETFs holding XtalPi Holdings Limited (weight per latest SEC filing): VXUS 0.01%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
What's Inside Your ETF Portfolio and the ETF overlap check show how much XtalPi Holdings Limited overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to XtalPi Holdings Limited
| Stock | Shared ETFs | r |
|---|---|---|
| XtalPi Holdings Limited | – | – |
| CSPC Pharmaceutical Group Limited | 10 | – |
| Sinopharm Group | 10 | – |
| 3SBio | 10 | – |
| BeOne Medicines | 10 | – |
| Sichuan Kelun-Biotech Biopharmaceutical | 10 | – |
| Akeso | 10 | – |
| RemeGen | 10 | – |
| Legend Biotech Corp. Sponsored | 10 | – |
These stocks reach a portfolio through largely the same funds as XtalPi Holdings Limited. “Shared ETFs” counts the funds that hold both.


